CD19 and graft versus host disease: Moreover, an increased risk for GVHD has been observed, restricting its application in particular early after transplantation when the risk of relapse is most pronounced.23 25 Therefore, we focused on the effects of checkpoint inhibition on CD19-CAR-iNKT-cell functionality.